CRISPR Therapeutics AGCRSPNASDAQ
Loading
Income Tax Expense Over TimeStrong
Percentile Rank100
5Y CAGR+35.0%
Studio
Year-over-Year Change

Income taxes paid or accrued

5Y CAGR
+35.0%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
4.5x
Strong expansion
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$3.63M+1.3%
2024$3.59M+24.2%
2023$2.89M+988.6%
2022$-325000.00-117.4%
2021$1.87M+131.1%
2020$809000.00+80.6%
2019$448000.00-19.0%
2018$553000.00-68.4%
2017$1.75M+261.4%
2016$484000.00-